Published in
Elsevier, The Lancet Respiratory Medicine, 2(5), p. 107-118
DOI: 10.1016/s2213-2600(16)30427-1
Links
Tools
Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study
Journal article published in 2017 by
Michael W. Konstan,
Edward F. McKone,
Richard B. Moss,
Gautham Marigowda,
Simon Tian,
David Waltz,
Xiaohong Huang,
Barry Lubarsky,
Jaime Rubin,
Stefanie J. Millar,
David J. Pasta,
Nicole Mayer-Hamblett,
Christopher H. Goss 
,
Wayne Morgan,
Gregory S. Sawicki
,
Wayne Morgan,
Gregory S. Sawicki
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 